|
TTC9C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.073600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.109030E-01 |
| Normal-vs-Stage2 |
3.984100E-02 |
| Normal-vs-Stage3 |
1.239270E-03 |
| Normal-vs-Stage4 |
5.164000E-02 |
| Stage1-vs-Stage2 |
3.383200E-01 |
| Stage1-vs-Stage3 |
1.590060E-02 |
| Stage1-vs-Stage4 |
4.460000E-01 |
| Stage2-vs-Stage3 |
4.362800E-01 |
| Stage2-vs-Stage4 |
8.535800E-01 |
| Stage3-vs-Stage4 |
3.071600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.695900E-02 |
| Normal-vs-AfricanAmerican |
1.539040E-01 |
| Normal-vs-Asian |
1.360830E-01 |
| Caucasian-vs-AfricanAmerican |
9.174000E-01 |
| Caucasian-vs-Asian |
8.387600E-01 |
| AfricanAmerican-vs-Asian |
8.108200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.800600E-03 |
| Normal-vs-Female |
6.006200E-02 |
| Male-vs-Female |
2.565700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.235200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.118400E-02 |
| Normal-vs-Age(61-80Yrs) |
8.810600E-04 |
| Normal-vs-Age(81-100Yrs) |
2.910100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.869600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.617500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.283020E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.126500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.685380E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.732400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.801400E-01 |
| Classical-VS-Follicular |
8.164600E-04 |
| Classical-VS-Other |
7.112400E-01 |
| Classical-VS-Normal |
1.336190E-01 |
| Tall-VS-Follicular |
7.600300E-02 |
| Tall-VS-Other |
7.790200E-01 |
| Tall-VS-Normal |
2.401400E-01 |
| Follicular-VS-Other |
5.919200E-01 |
| Follicular-VS-Normal |
7.003700E-04 |
| Other-VS-Normal |
4.849000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.224400E-02 |
| Normal-vs-N1 |
1.755050E-03 |
| N0-vs-N1 |
9.842200E-02 |
|
|
